Successful therapy to a progressive tumor using monoclonal-antibodies to T-cell regulatory molecules and interleukin-2.

Int J Oncol

UNIV N CAROLINA,DEPT PERIODONT,CHAPEL HILL,NC 27514. UNIV N CAROLINA,DEPT MICROBIOL IMMUNOL,CHAPEL HILL,NC 27514. YALE UNIV,SCH MED,DEPT PATHOL,NEW HAVEN,CT 06510. YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510.

Published: September 1993

Weekly injections of monoclonal antibodies (mAb) to T-cell regulatory molecules, into animals challenged with a progressively growing epithelial cell tumor 3152-PRO, decreased tumor incidence and caused significantly slower tumor growth, compared with animals given identical treatments of control rat mAb. Some of the mAb showed significant synergy with rIL-2 in the successful therapeutic treatment of 3152-PRO. Furthermore, spleen cells from treated mice generated strong tumor-specific cytotoxic activity. The successful elimination of progressively growing 3152-PRO tumor rendered animals specifically resistant to a secondary challenge of 3152-PRO tumor cells, but not to 2237-PRO or 3256-PRO, two other, noncrossreactive tumors.

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.3.3.503DOI Listing

Publication Analysis

Top Keywords

t-cell regulatory
8
regulatory molecules
8
progressively growing
8
3152-pro tumor
8
tumor
6
successful therapy
4
therapy progressive
4
progressive tumor
4
tumor monoclonal-antibodies
4
monoclonal-antibodies t-cell
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!